Oncternal Therapeutics, Inc. (ONCT)

Oncternal Therapeutics Market Cap

Oncternal Therapeutics has a market cap or net worth of $20.72 million as of July 22, 2024. Its market cap has increased by 0.57% in one year.

• Market Cap: 20.72M
• Enterprise Value: -6.03M
• 1-Year Change: 0.57%
• Ranking: #4934
• Category: Nano-Cap
• Stock Price: $7.00

Market Cap Chart

Since February 3, 2004, Oncternal Therapeutics's market cap has decreased from $317.20M to $20.72M, a decrease of -93.47%. That is a compound annual growth rate of -12.48%.

Market Cap History

Date	Market Cap	% Change
Jul 19, 2024	20.70M	-34.49%
Dec 29, 2023	31.60M	-43.87%
Dec 30, 2022	56.30M	-49.82%
Dec 31, 2021	112.20M	2.47%
Dec 31, 2020	109.50M	80.10%
Dec 31, 2019	60.80M	223.40%
Dec 31, 2018	18.80M	-93.13%
Dec 29, 2017	273.80M	225.56%
Dec 30, 2016	84.10M	-14.45%
Dec 31, 2015	98.30M	77.12%
Dec 31, 2014	55.50M	-46.79%
Dec 31, 2013	104.30M	-60.46%
Dec 31, 2012	263.80M	25.02%
Dec 30, 2011	211.00M	56.99%
Dec 31, 2010	134.40M	-12.16%
Dec 31, 2009	153.00M	-75.02%
Dec 31, 2008	612.40M	22.21%
Dec 31, 2007	501.10M	-9.42%
Dec 29, 2006	553.20M	136.11%
Dec 30, 2005	234.30M	-29.56%
Dec 31, 2004	332.60M	4.85%
Feb 3, 2004	317.20M	-

View and export this data all the way back to 2004. Sign Up Today.

Related Stocks

Company	Market Cap
AIM ImmunoTech	21.16M
Cumberland Pharmaceuticals	21.00M
Cosmos Health	21.00M
Jaguar Health	20.83M
TRxADE HEALTH	20.73M
BiomX	20.59M
Singular Genomics Systems	20.44M
Iterum Therapeutics	20.20M